Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1192-17-2

Post Buying Request

1192-17-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1192-17-2 Usage

General Description

2,2-diethyloxirane, also known as ethyl vinyl ether, is a chemical compound with the formula C6H12O. It is a colorless liquid with a faintly sweet odor, and it is highly flammable. 2,2-diethyloxirane is used as a solvent and as an intermediate in the synthesis of other organic compounds. It can also be used as a monomer in the production of polymer materials. However, it is considered to be a hazardous chemical, and exposure to it can cause irritation to the skin, eyes, and respiratory tract. It is important to handle 2,2-diethyloxirane with caution and to use appropriate safety measures when working with this chemical.

Check Digit Verification of cas no

The CAS Registry Mumber 1192-17-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,9 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1192-17:
(6*1)+(5*1)+(4*9)+(3*2)+(2*1)+(1*7)=62
62 % 10 = 2
So 1192-17-2 is a valid CAS Registry Number.

1192-17-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,2-diethyloxirane

1.2 Other means of identification

Product number -
Other names Oxirane,2-diethyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1192-17-2 SDS

1192-17-2Relevant articles and documents

Molybdenum containing surface complex for olefin epoxidation

Yang, Qihua,Coperet, Christophe,Li, Can,Basset, Jean-Marie

, p. 319 - 323 (2003)

Silica-supported molybdenum surface complexes were prepared by the reaction between (N≡)Mo(OtBu)3 and silica via displacement of the tert-butoxy ligands for siloxyls from the silica surface. The structure of the surface molybdenum complexes was well defined by in-situ FT-IR, elemental analysis, 1H NMR and 13C CP/MAS NMR techniques. The surface complexes could undergo alcoholysis reaction with CD3OD and CH3OH in the same way as free (N≡)Mo(OtBu)3 and they show high catalytic activity and selectivity in olefin epoxidation. Initial rates up to 24.9 mmol epoxide (mmol Mo)-1 min-1 were achieved in the epoxidation of cyclohexene using TBHP as oxidant.

Regioselective Carbonylation of 2,2-Disubstituted Epoxides: An Alternative Route to Ketone-Based Aldol Products

Hubbell, Aran K.,Lapointe, Anne M.,Lamb, Jessica R.,Coates, Geoffrey W.

supporting information, p. 2474 - 2480 (2019/02/14)

We report the regioselective carbonylation of 2,2-disubstituted epoxides to β,β-disubstituted β-lactones. Mechanistic studies revealed epoxide ring-opening as the turnover limiting step, an insight that facilitated the development of improved reaction conditions using weakly donating, ethereal solvents. A wide range of epoxides can be carbonylated to β-lactones, which are subsequently ring-opened to produce ketone-based aldol adducts, providing an alternative to the Mukaiyama aldol reaction. Enantiopure epoxides were demonstrated to undergo the carbonylation/ring-opening process with retention of stereochemistry to form enantiopure β-hydroxy esters.

AMIDE DERIVATIVES FOR GPR119 AGONIST

-

Page/Page column 35, (2015/06/11)

The present invention relates to novel amide derivatives, stereoisomers thereof or pharmaceutically acceptable salts thereof; methods for preparing the compound; and pharmaceutical compositions comprising the compound. The novel amide derivatives, according to the present invention, having an effect as GPR119 agonist can be used for treatment of metabolic disorders, including diabetes mellitus (especially type II) and related disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1192-17-2